Changes observed in diabetic retinopathy: Eight-year follow-up of a Spanish population

British Journal of Ophthalmology

Volumn 100, Issue 10, 2016, Pages 1366-1371

  Romero Aroca, Pedro ^a   De La Riva Fernandez, Sofia ^a   Valls Mateu, Aida ^b   Sagarra Alamo, Ramon ^b   Moreno Ribas, Antonio ^b   Soler, Nuria ^a  

^a HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

^b UNIVERSITAT ROVIRA I VIRGILI   (Spain)

Author keywords

Epidemiology; Macula; Public health; Retina; Telemedicine

Indexed keywords

HEMOGLOBIN A1C;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; CAUCASIAN; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE COURSE; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT REFERRAL; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETINOGRAPHY; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; VERY ELDERLY; CLINICAL TRIAL; COMPLICATION; DIABETES MELLITUS, TYPE 2; HEALTH SURVEY; MIDDLE AGED; MULTICENTER STUDY; PREVALENCE; PROCEDURES; SPAIN;

ADULT; AGED; AGED, 80 AND OVER; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PREVALENCE; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SPAIN;

EID: 84956600490     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2015-307689     Document Type: Article

References (25)

1. International Diabetes federation. IDF DIABETES ATLAS, 6TH Edition. Brussels, Belgium. 2013. http://www.idf.org/diabetesatlas
2. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010;87:4-14.
3. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2000;23:S4-S19.
4. Bourne RR, Jonas JB, Flaxman SR, et al, Vision loss expert group of the global burden of disease study. Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe: 1990-2010. Br J Ophthalmol 2014;98:629-38.
5. Jones S, Edwards RT. Diabetic retinopathy screening: a systematic review of the economic evidence. Diabet Med 2010;27:249-56.
6. Romero P, Sagarra R, Ferrer J, et al. The incorporation of family physicians in the assessment of diabetic retinopathy by non-mydriatic fundus camera. Diabetes Res Clin Pract 2010;88:184-8.
7. Romero-Aroca P, Sagarra-Alamo R, Basora-Gallisa J, et al. Prospective comparison of two methods of screening for diabetic retinopathy by nonmydriatic fundus camera. Clin Ophthalmol 2010;4:1481-8.
8. Romero-Aroca P, Fernández-Balart J, Baget-Bernaldiz M, et al. Changes in the diabetic retinopathy epidemiology after 14 years in a population of Type 1 and 2 diabetic patients after the new diabetes mellitus diagnosis criteria and a more strict control of the patients. J Diabetes Complicat 2008;23:229-38.
9. Aldington SJ, Kohner EM Meuer S, et al. Methodology for retinal photography and assessment of diabetic retinopathy: the EURODIAB IDDM complications study. Diabetologia 1995;38:437-44.
10. Klein R, Klein BE, Moss SE, et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XIV. Ten year incidence and progression of diabetic retinopathy. Arch Ophthalmol 1994;112:1217-28.
11. Wilkinson CP, Ferris FL III, Klein RE, et al, Global Diabetic Retinopathy Project Group. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 2003;110:1677-82.
12. ETDRS. Detection of diabetic macular oedema study n°5. Ophthalmology 1989;96:746-51.
13. Yau JW, Rogers SL, Kawasaki R, et al., Meta-Analysis for Eye Disease [META-EYE] Study Group. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 2012;35:556-64.
14. Valdés S, Garciá-Torres F, Maldonado-Araque C, et al, Di@bet.es study group. Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Di@bet.es Study. Diabetologia 2012;55:88-93.
15. Jones CD, Greenwood RH, Misra A, et al. Incidence and progression of diabetic retinopathy during 17 years of a population-based screening program in England. Diabetes Care. 2012;35:592-6.
16. Thomas RL, Dunstan F, Luzio SD, et al. Incidence of diabetic retinopathy in people with type 2 diabetes mellitus attending the Diabetic Retinopathy Screening Service for Wales: retrospective analysis. BMJ 2012;344:e874.
17. Looker HC, Nyangoma SO, Cromie DT, et al. Scottish Diabetes Research Network Epidemiology Group; Scottish Diabetic Retinopathy Collaborative. Rates of referable eye disease in the Scottish National Diabetic Retinopathy Screening Programme. Br J Ophthalmol 2014;98:790-5.
18. Andonegui J, Zurutuza A, de Arcelus MP, et al. Diabetic retinopathy screening with non-mydriatic retinography by general practitioners: 2-year results. Prim Care Diabetes 2012;6:201-5.
19. Santos-Bueso E, Fernández-Vigo J, Fernández-Pérez C, et al. Prevalencia de retinopatiá diabética en la Comunidad Autónoma de Extremadura: 1997-2001 (Proyecto Extremadura para Prevención de la Ceguera). Arch Soc Esp Oftalmol 2005;80:187-94.
20. LeCaire TJ, Palta M, Klein R, et al. Assessing progress in retinopathy outcomes in type 1 diabetes: comparing findings from the wisconsin diabetes registry study and the wisconsin epidemiologic study of diabetic retinopathy. Diabetes Care 2013;36:631-7.
21. Lecaire T, Palta M, Zhang H, et al. Lower-than-expected prevalence and severity of retinopathy in an incident cohort followed during the first 4-14 years of type 1 diabetes: the Wisconsin Diabetes Registry Study. Am J Epidemiol 2006;164:143-50.
22. Rodriguez-Poncelas A, Miravet-Jiménez S, Casellas A, et al. Prevalence of diabetic retinopathy in individuals with type 2 diabetes who had recorded diabetic retinopathy from retinal photographs in Catalonia (Spain). Br J Ophthalmol 2015;99:1628-33.
23. Romero-Aroca P. Targeting the pathophysiology of diabetic macular edema. Diabetes Care 2010;33:2484-5.
24. Sasongko M, Wong T, Nguyen T, et al. Novel versus traditional risk markers for diabetic retinopathy. Diabetologia 2012;55:666-70.
25. Man RE, Sasongko MB, Wang JJ, et al. The association of estimated glomerular filtration rate with diabetic retinopathy and macular oedema. Invest Ophthalmol Vis Sci 2015;56:4810-16.